A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

NCT05734105 · clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Deciphera Pharmaceuticals, LLC